ACM Central Laboratory Expands its Business Development Team
ACM Central Laboratory, a central lab specializing in safety and specialty testing for clinical trials, announced expansion of its business development team by more than 100%.
Rochester, New York -- April 4, 2005 -- ACM Central Laboratory, a central lab specializing in safety and specialty testing for clinical trials, announced expansion of its business development team by more than 100%. Overwhelming demand for ACM Central Laboratory Services by new and existing customers has led to this growth.
ACM Central Laboratory Services has added U.S. business development directors in the Northeast, Southeast and on the West Coast. Tim Robey, Scott Keddy, Tab Moore and James Naumann join ACM's team of talented professionals. Highly experienced, these directors bring extensive knowledge of the clinical development industry. Their experience includes operational, clinical and business development responsibilities within contract research organizations (CRO), central labs, and pharmaceutical and biotech companies. In addition to sales in their respective regions, the directors will be responsible for ongoing client communication and ensuring customer satisfaction.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
